AI assistant

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Microbot Medical Inc. Director's Dealing 2014

Jan 10, 2014

33819_dirs_2014-01-10_54e5be63-ebae-4bf9-a0f7-34abdfdb9ad2.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: STEMCELLS INC (STEM)
CIK: 0000883975
Period of Report: 2014-01-01

Reporting Person: SCHIFFMAN GREGORY T (Chief Financial Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2014-01-01	Common Stock	A	350000	$0.00	Acquired	350000	Direct

Footnotes

F1: Restricted stock units, with 1/4 vesting on January 1, 2015, January 1, 2016, January 1, 2017, and January 1, 2018.

F2: Consists of 350,000 restricted stock units, with 87,500 vesting on each of January 1, 2015, January 1, 2016, January 1, 2017, and January 1, 2018.